Charles Schwab’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.96M | Buy |
646,256
+94,486
| +17% | +$617K | ﹤0.01% | 2565 |
|
|
2026
Q1 | $3.81M | Buy |
551,770
+51,255
| +10% | +$395K | ﹤0.01% | 2509 |
|
|
2025
Q4 | $4.41M | Buy |
500,515
+11,579
| +2% | +$63.7K | ﹤0.01% | 2508 |
|
|
2025
Q3 | $2.44M | Buy |
488,936
+38,729
| +9% | +$179K | ﹤0.01% | 2702 |
|
|
2025
Q2 | $2.12M | Sell |
450,207
-25,658
| -5% | -$112K | ﹤0.01% | 2648 |
|
|
2025
Q1 | $2.18M | Sell |
475,865
-82,581
| -15% | -$385K | ﹤0.01% | 2584 |
|
|
2024
Q4 | $2.67M | Sell |
558,446
-37,764
| -6% | -$181K | ﹤0.01% | 2589 |
|
|
2024
Q3 | $2.8M | Buy |
596,210
+3,473
| +0.6% | +$18.6K | ﹤0.01% | 2604 |
|
|
2024
Q2 | $3.35M | Sell |
592,737
-75,443
| -11% | -$390K | ﹤0.01% | 2526 |
|
|
2024
Q1 | $2.75M | Buy |
668,180
+23,051
| +4% | +$92.3K | ﹤0.01% | 2507 |
|
|
2023
Q4 | $2.72M | Sell |
645,129
-1,119
| -0.2% | -$4.51K | ﹤0.01% | 2523 |
|
|
2023
Q3 | $2.79M | Buy |
646,248
+8,176
| +1% | +$45.4K | ﹤0.01% | 2500 |
|
|
2023
Q2 | $4.2M | Buy |
638,072
+5,715
| +0.9% | +$36.6K | ﹤0.01% | 2302 |
|
|
2023
Q1 | $4.29M | Sell |
632,357
-32,678
| -5% | -$230K | ﹤0.01% | 2279 |
|
|
2022
Q4 | $4.91M | Buy |
665,035
+20,179
| +3% | +$197K | ﹤0.01% | 2219 |
|
|
2022
Q3 | $6.37M | Buy |
644,856
+10,378
| +2% | +$110K | ﹤0.01% | 2093 |
|
|
2022
Q2 | $6.92M | Sell |
634,478
-44,904
| -7% | -$465K | ﹤0.01% | 2024 |
|
|
2022
Q1 | $7.68M | Sell |
679,382
-27,910
| -4% | -$367K | ﹤0.01% | 2081 |
|
|
2021
Q4 | $11.1M | Buy |
707,292
+67,410
| +11% | +$1.17M | ﹤0.01% | 1947 |
|
|
2021
Q3 | $11M | Buy |
639,882
+84,975
| +15% | +$1.49M | ﹤0.01% | 1953 |
|
|
2021
Q2 | $11.9M | Buy |
554,907
+144,050
| +35% | +$2.58M | ﹤0.01% | 1910 |
|
|
2021
Q1 | $6.17M | Buy |
410,857
+54,575
| +15% | +$883K | ﹤0.01% | 2191 |
|
|
2020
Q4 | $4.68M | Buy |
356,282
+1,731
| +0.5% | +$20.8K | ﹤0.01% | 2250 |
|
|
2020
Q3 | $3.42M | Sell |
354,551
-923
| -0.3% | -$9.87K | ﹤0.01% | 2256 |
|
|
2020
Q2 | $4.07M | Buy |
355,474
+26,973
| +8% | +$305K | ﹤0.01% | 2122 |
|
|
2020
Q1 | $3.4M | Sell |
328,501
-95,974
| -23% | -$1.19M | ﹤0.01% | 2031 |
|
|
2019
Q4 | $6.97M | Sell |
424,475
-104,103
| -20% | -$1.57M | ﹤0.01% | 1849 |
|
|
2019
Q3 | $7.02M | Buy |
528,578
+73,819
| +16% | +$1.03M | ﹤0.01% | 1804 |
|
|
2019
Q2 | $6.41M | Buy |
454,759
+18,447
| +4% | +$294K | ﹤0.01% | 1851 |
|
|
2019
Q1 | $8.03M | Buy |
436,312
+72,121
| +20% | +$1.64M | 0.01% | 1727 |
|
|
2018
Q4 | $9.52M | Sell |
364,191
-43,027
| -11% | -$1.01M | 0.01% | 1493 |
|
|
2018
Q3 | $9.35M | Buy |
407,218
+15,279
| +4% | +$312K | 0.01% | 1683 |
|
|
2018
Q2 | $7.47M | Buy |
391,939
+9,802
| +3% | +$164K | 0.01% | 1780 |
|
|
2018
Q1 | $6.44M | Sell |
382,137
-99,875
| -21% | -$1.67M | 0.01% | 1798 |
|
|
2017
Q4 | $7.33M | Buy |
482,012
+9,496
| +2% | +$141K | 0.01% | 1690 |
|
|
2017
Q3 | $8.46M | Buy |
472,516
+11,647
| +3% | +$195K | 0.01% | 1543 |
|
|
2017
Q2 | $7.51M | Buy |
460,869
+16,183
| +4% | +$233K | 0.01% | 1545 |
|
|
2017
Q1 | $6.23M | Buy |
444,686
+10,383
| +2% | +$148K | 0.01% | 1630 |
|
|
2016
Q4 | $6.93M | Buy |
434,303
+38,338
| +10% | +$616K | 0.01% | 1524 |
|
|
2016
Q3 | $6.59M | Buy |
395,965
+82,877
| +26% | +$1.12M | 0.01% | 1462 |
|
|
2016
Q2 | $3.5M | Buy |
313,088
+12,909
| +4% | +$125K | ﹤0.01% | 1781 |
|
|
2016
Q1 | $2.51M | Buy |
300,179
+31,546
| +12% | +$259K | ﹤0.01% | 1929 |
|
|
2015
Q4 | $2.5M | Buy |
268,633
+194,080
| +260% | +$1.94M | ﹤0.01% | 1957 |
|
|
2015
Q3 | $841K | Hold |
74,553
| – | – | ﹤0.01% | 2442 |
|
|
2015
Q2 | $947K | Hold |
74,553
| – | – | ﹤0.01% | 2438 |
|
|
2015
Q1 | $694K | Buy |
74,553
+13,300
| +22% | +$150K | ﹤0.01% | 2520 |
|
|
2014
Q4 | $878K | Hold |
61,253
| – | – | ﹤0.01% | 2415 |
|
|
2014
Q3 | $636K | Buy |
61,253
+13,953
| +29% | +$183K | ﹤0.01% | 2501 |
|
|
2014
Q2 | $766K | Hold |
47,300
| – | – | ﹤0.01% | 2445 |
|
|
2014
Q1 | $769K | Hold |
47,300
| – | – | ﹤0.01% | 2409 |
|
|
2013
Q4 | $587K | Hold |
47,300
| – | – | ﹤0.01% | 2532 |
|
|
2013
Q3 | $521K | Buy |
47,300
+9,700
| +26% | +$104K | ﹤0.01% | 2534 |
|
|
2013
Q2 | $316K | Buy |
+37,600
| New | +$253K | ﹤0.01% | 2711 |
|
Other funds holding VNDA
ACM
Charles Schwab's VNDA Position: Q2 2026 in Review
Charles Schwab increased its Vanda Pharmaceuticals (VNDA) stake by 17% in Q2 2026, buying an estimated $617K and bringing the position to 646,256 shares worth $3.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2565.
Charles Schwab first reported a position in VNDA in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.9M in Q2 2021. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.
- Charles Schwab held 646,256 shares of Vanda Pharmaceuticals worth $3.96M as of Q2 2026.
- Charles Schwab bought 94,486 Vanda Pharmaceuticals shares in Q2 2026, an estimated $617K.
- Vanda Pharmaceuticals made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2565 holding.
- Charles Schwab first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Vanda Pharmaceuticals position peaked at $11.9M in Q2 2021.
- 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.